301 related articles for article (PubMed ID: 10738218)
21. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction.
Pine SR; Yin C; Matloub YH; Sabaawy HE; Sandoval C; Levendoglu-Tugal O; Ozkaynak MF; Jayabose S
J Mol Diagn; 2005 Feb; 7(1):127-32. PubMed ID: 15681484
[TBL] [Abstract][Full Text] [Related]
22. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
[TBL] [Abstract][Full Text] [Related]
23. Lactate dehydrogenase isoenzymes in blood and cerebrospinal fluid from healthy beagles.
Heavner JE; Colaianne J; Roper M
Am J Vet Res; 1986 Aug; 47(8):1772-5. PubMed ID: 3752688
[TBL] [Abstract][Full Text] [Related]
24. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons.
Corcoran C; Rebe K; van der Plas H; Myer L; Hardie DR
J Clin Virol; 2008 Aug; 42(4):433-6. PubMed ID: 18455472
[TBL] [Abstract][Full Text] [Related]
25. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma, leukemia, and pleiocytosis in cerebrospinal fluid: is accurate cytopathologic diagnosis possible based on morphology alone?
Wu JM; Georgy MF; Burroughs FH; Weir EG; Rosenthal DL; Ali SZ
Diagn Cytopathol; 2009 Nov; 37(11):820-4. PubMed ID: 19526571
[TBL] [Abstract][Full Text] [Related]
28. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.
Rhodes CH; Glantz MJ; Glantz L; Lekos A; Sorenson GD; Honsinger C; Levy NB
Cancer; 1996 Feb; 77(3):543-8. PubMed ID: 8630963
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system lymphomas in organ allograft recipients.
Penn I; Porat G
Transplantation; 1995 Jan; 59(2):240-4. PubMed ID: 7839447
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
[TBL] [Abstract][Full Text] [Related]
32. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
Aviles A; Gómez R; Salas J
Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid approach on neuro-oncology.
Gomes HR
Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
[TBL] [Abstract][Full Text] [Related]
34. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells.
Babusíková O; Zelezníková T
Neoplasma; 2004; 51(5):345-51. PubMed ID: 15640938
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
Sancho JM; Orfao A; Quijano S; García O; Panizo C; Pérez-Ceballos E; Deben G; Salar A; González-Barca E; Alonso N; García-Vela JA; Capote J; Peñalver FJ; Provencio M; Arias J; Plaza J; Caballero D; Morado M; Feliu E; Ribera JM;
Eur J Haematol; 2010 Oct; 85(4):321-8. PubMed ID: 20528905
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.
Galati D; Di Noto R; Del Vecchio L
Leuk Res; 2013 Mar; 37(3):231-7. PubMed ID: 23287431
[TBL] [Abstract][Full Text] [Related]
37. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
38. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious.
Schinstine M; Filie AC; Wilson W; Stetler-Stevenson M; Abati A
Cancer; 2006 Jun; 108(3):157-62. PubMed ID: 16649227
[TBL] [Abstract][Full Text] [Related]
39. [Involvement of CNS in leukaemia and lymphomas--CSF meningeosis and immunocytochemical phenotyping].
Lehmitz R; Pahnke J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S37-8. PubMed ID: 19685390
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of lactic dehydrogenase (LDH) and its isoenzyme 5 in the cerebrospinal fluid (CSF) of cancer patients].
Simó-Camps E; Grau A; Bofill D; Zaragoza J; Pascual J; Sirvent JJ
Med Clin (Barc); 1983 Jun; 81(3):99-102. PubMed ID: 6888079
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
